Patients with PSA levels within the normal range of 0–4 ng/ml are usually only diagnosed with prostate cancer in cases of concomitant urinary and/or pain symptoms that are associated with the local extent and metastatic diffusion of the disease. This evidence concerns the gene KLK3 and prostate carcinoma.